US Patent 7473761 | US Patents | Expiry | Expiration | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
NEW Find Prospects
- Prospector
Drugs in Dev.
News
Blog
Market Place
Login

Recordati

Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

Contact Supplier

Lupin Manufacturing Solutions – delivering high-quality APIs & end-to-end CDMO services for faster, cost-effective drug development.

Contact Supplier

Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

Contact Supplier

Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

Contact Supplier

AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

Contact Supplier

pharmacompass-2-2026-02-09

Recordati

VIRTUAL BOOTH, Contact Details

VIRTUAL BOOTH
CONTACT DETAILS
Google Map, LinkedIn, Emails...

EVENTS

Webinars & Exhibitions

Webinars & Exhibitions

DIGITAL CONTENT

Interview #SpeakPharma, Vlog #PharmaReel, Data Compilation #PharmaFlow, 46 News #PharmaBuzz

Interview #SpeakPharma
Vlog #PharmaReel
Data Compilation #PharmaFlow
46 News #PharmaBuzz

ACTIVE PHARMA INGREDIENTS

54 All APIs, 45 USDMF, 14 CEP/COS, 12 JDMF, 14 NDC API, 20 Listed APIs

54 All APIs
45 USDMF
14 CEP/COS
12 JDMF
14 NDC API
20 Listed APIs

DEVELOPMENTS

29 Drugs in Development

29 Drugs in Development

INTERMEDIATES

16 ALL Intermediates

16 ALL Intermediates

FINISHED DOSAGE FORMULATIONS

460 FDF Dossiers, 24 FDA Orange Book, 421 Europe, 15 Australia

460 FDF Dossiers
24 FDA Orange Book
421 Europe
15 Australia

INSPECTIONS & REGISTRATIONS

1 FDA, 1 GDUFA, 3 Third-Party Audit

1 FDA
1 GDUFA
3 Third-Party Audit

Xls

Filters

Reset all filters

Filters

FILTER :

filter Applicant Reset all filters

8 All

01 8RECORDATI RARE

filter Patent Number Reset all filters

8 All

01 87473761

filter API Patent Reset all filters

8 All

01 8Y

filter FDF Patent Reset all filters

8 All

01 8Y

filter Expiration Date Reset all filters

8 All

01 82026-12-14

01

RECORDATI RARE

PASIREOTIDE DIASPARTATE

euroPLX 90 Lisbon

Not Confirmed

RECORDATI RARE

euroPLX 90 Lisbon

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2026-12-14

PASIREOTIDE DIASPARTATE

US Patent Number : 7473761

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 200677

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2026-12-14

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

02

RECORDATI RARE

PASIREOTIDE PAMOATE

euroPLX 90 Lisbon

Not Confirmed

RECORDATI RARE

euroPLX 90 Lisbon

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2026-12-14

PASIREOTIDE PAMOATE

US Patent Number : 7473761

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 203255

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2026-12-14

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

03

RECORDATI RARE

PASIREOTIDE PAMOATE

euroPLX 90 Lisbon

Not Confirmed

RECORDATI RARE

euroPLX 90 Lisbon

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2026-12-14

PASIREOTIDE PAMOATE

US Patent Number : 7473761

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 203255

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2026-12-14

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

04

RECORDATI RARE

PASIREOTIDE PAMOATE

euroPLX 90 Lisbon

Not Confirmed

RECORDATI RARE

euroPLX 90 Lisbon

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2026-12-14

PASIREOTIDE PAMOATE

US Patent Number : 7473761

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 203255

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2026-12-14

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

05

RECORDATI RARE

PASIREOTIDE PAMOATE

euroPLX 90 Lisbon

Not Confirmed

RECORDATI RARE

euroPLX 90 Lisbon

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2026-12-14

PASIREOTIDE PAMOATE

US Patent Number : 7473761

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 203255

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2026-12-14

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

06

RECORDATI RARE

PASIREOTIDE DIASPARTATE

euroPLX 90 Lisbon

Not Confirmed

RECORDATI RARE

euroPLX 90 Lisbon

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2026-12-14

PASIREOTIDE DIASPARTATE

US Patent Number : 7473761

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 200677

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2026-12-14

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

07

RECORDATI RARE

PASIREOTIDE PAMOATE

euroPLX 90 Lisbon

Not Confirmed

RECORDATI RARE

euroPLX 90 Lisbon

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2026-12-14

PASIREOTIDE PAMOATE

US Patent Number : 7473761

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 203255

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2026-12-14

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

08

RECORDATI RARE

PASIREOTIDE DIASPARTATE

euroPLX 90 Lisbon

Not Confirmed

RECORDATI RARE

euroPLX 90 Lisbon

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2026-12-14

PASIREOTIDE DIASPARTATE

US Patent Number : 7473761

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 200677

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2026-12-14

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.